Current partner codePEPTIDESDE
NCT07604051·Phase 4·INTERVENTIONAL

Termination of Pregnancy in Previous Scarred Uterus: PGE1 Versus Cervical Folleys

Status

Completed

Phase

Phase 4

Enrollment

60

Locations

1

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

As mentioned above, previous studies have shown variable results and the best among these two is still in debate, so there must be re-evaluation of results on this topic. The rationale of this study is to compare the efficacy (in terms of complete evacuation) of PGE1 versus cervical folleys in termination of pregnancy. This study not only will lead to the decision regarding selection of appropriate method with less comorbidities but also add in the literature regarding the women health improvement that is a matter of concern in 21st century. Then based on the results of my study, these particular patients can be provided with better way of second trimester termination of pregnancy in order to reduce the complications of the incomplete miscarriage as well as morbidity and mortality of these patients

Full detailed description

Among unintended 205 million pregnancies that occur each year worldwide, about 20% of them end in induced abortion. Majority of these abortions occur during the first trimester of pregnancy. The second trimester of pregnancy is subdivided into an early period between 13-20 weeks and a late period between 20-28 weeks. Advanced screening techniques have led to an increase in the detection of congenital malformations with subsequent gradual increase in second trimester termination of pregnancy which represents 10-15% of total abortions performed worldwide. Termination in the second trimester is more risky than during first trimester. So the pharmacologic management seems to be an appealing alternative to surgical evacuation. There is a wide range of prostaglandin preparations available which can be used for cervical ripening or induction of labour. Misoprostol is a synthetic prostaglandin E1 analogue. It was first used in obstetrics to induce abortion in 1988. Now it is widely used for induction of labour, termination of pregnancy and management of postpartum haemorrhage but still its use in obstetrics is not approved by FDA. Mechanical dilatation of cervix to induce abortion or labour is also known since 1833. The Foleys catheter traction is the cheapest, safest and successful mechanical method of cervical dilatation according to various studies. The decision regarding the effectiveness of any of the above two modality in women with previous cesarean is still a debate

Interventions

Treatment arms and agents.

DRUG

PGE1 tablet

Group A will receive 200µg orally five doses six hours apart. If the patient did not abort after the first course, the same regimen will be repeated 24 hours after the start of the first dose of misoprostol

DEVICE

cervical folleys

Group B will receive cervical foleys. Foley's catheter group will be put in lithotomy position in examination room, vulva vagina will be cleaned with pyodine and sterile Sim's speculum will be introduced in the vagina, holding anterior cervical lip with sponge holding forceps and with the help of another sponge holding forceps a Foleys catheter no 14 Fr will be passed in the cervix into the extra amniotic space and balloon will be inflated with 30ml saline. A urine bag will be filled with 500ml saline will be attached to the catheter for traction. As soon as the catheter will be expelled reassessment of the dilatation of the cervix will be done and if needed infusion oxytocin will be started

Timeline

From registration to results.

  1. First posted

    May 22, 2026

  2. Study start

    Nov 13, 2025

  3. Primary completion

    Apr 12, 2026

  4. Study completion

    May 12, 2026

  5. Results posted

    Not reported

  6. Registry updated

    May 22, 2026

Outcomes

What the study measures.

Primary outcomes

Percentage of efficacy

Time frame · 48 hours

It refers to the ability of PGE1 or cervical Foleys to achieve complete abortion within 48 hours during the second trimester of fetal demise

Secondary outcomes

Not reported in the indexed record.

Eligibility

Who can take part.

Minimum age
20 Years
Maximum age
45 Years
Sex
FEMALE
Healthy volunteers
No

Inclusion Criteria: * All women presented for termination of pregnancy (as per-operational definition). * Patients with age 20-45 years Exclusion Criteria: * Women having multiple gestation. * Women having any complication of miscarriage like bleeding, chorioamnionitis, disseminated intravascular coagulopathy. * Women having any complication in previous cesarean like endometritis, re opening and scar dehiscence. * Patients with molar or ectopic pregnancy (assessed on ultrasonography).

Study locations

1 registered sites.

Pakistan. Showing up to 24 locations stored in the fast local snapshot.

Hilal-e-ahmar Hospital

Faisalabad, Punjab Province, Pakistan

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Oxytocin.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.